Topotecan (Hospira, Inc.)
Welcome to the PulseAid listing for the Topotecan drug offered from Hospira, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | TOPOTECAN |
SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-02-02 |
END MARKETING DATE: | 0000-00-00 |
Topotecan HUMAN PRESCRIPTION DRUG Details:
Item Description | Topotecan from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2011-02-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-0302_2f5fdefe-eb5a-48e2-b758-46699c1d20b6 |
PRODUCT NDC: | 0409-0302 |
APPLICATION NUMBER: | NDA200582 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: